Abstract
Purpose
Relapsing polychondritis (RPC) is a rare, multi-system, inflammatory disorder. Ocular disease is estimated to occur in 14–67% of patients with RPC, and any ocular structure can be affected. Published case reports and series of RPC were analysed to determine the frequency and nature of the ocular manifestations of RPC, including the age and gender distribution.
Methods
A literature search of the MEDLINE database for case reports and series on RPC was conducted in October 2021 using search terms [relapsing polychondritis (MeSH Major Topic)] OR [relapsing polychondritis (Title/Abstract)]. Articles were included if the diagnosis of RPC was confirmed using established diagnostic criteria and if the paper described the clinical features of patients with RPC.
Results
546 articles (454 case reports and 92 case series) described the clinical features in a total of 2414 patients with RPC.
49% of patients with RPC had ocular involvement, and this was a presenting feature in 21%. The most common ocular manifestations were scleritis (32%), episcleritis (31%) and uveitis (23%).
Conclusion
Many patients with RPC will be seen by an ophthalmologist during the course of their disease. Knowledge and awareness of RPC and its ocular manifestations is therefore essential to enable the ophthalmologist to make the diagnosis.
Similar content being viewed by others
References
Borgia F, Giuffrida R, Guarneri F et al (2018) Relapsing polychondritis: an updated review. Biomedicines 6(3):84
Kumakiri K, Sakamoto T, Karahashi T et al (2005) A case of relapsing polychondritis preceded by inner ear involvement. Auris Nasus Larynx 32(1):71–76
Stabler T, Piette J-C, Chevalier X et al (2004) Serum cytokine profiles in relapsing polychondritis suggest monocyte/macrophage activation. Arthritis Rheum 50(11):3663–3667
Valenzuela R, Cooperrider PA, Gogate P et al (1980) Relapsing polychondritis. Hum Pathol 11(1):19–22
Arnaud L, Mathian A, Haroche J et al (2014) Pathogenesis of relapsing polychondritis: a 2013 update. Autoimmun Rev 13(2):90–95
Yang CL, Brinckmann J, Rui HF et al (1993) Autoantibodies to cartilage collagens in relapsing polychondritis. Arch Dermatol Res 285(5):245–249
Trentham DE, Le CH (1998) Relapsing polychondritis. Ann Intern Med 129(2):114–122
Michet CJ, McKenna CH, Luthra HS et al (1986) Relapsing polychondritis. Ann Intern Med 104(1):74–78
McAdam LP, O’Hanlan MA, Bluestone R et al (1976) Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 55(3):193–215
Damiani JM, Levine HL (1979) Relapsing polychondritis—report of ten cases. Laryngoscope 89(6):929–946
Arnaud L, Devilliers H, Peng SL et al (2012) The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritis. Autoimmun Rev 12(2):204–209
Choy EHS, Chikanza IC, Kinglsey GH et al (1991) Chimaeric anti-CD4 monoclonal antibody for relapsing polychondritis. Lancet 338(8764):450
Lubbe PVD, Miltenburg A, Breedveld F (1991) Anti-CD4 monoclonal antibody for relapsing polychondritis. Lancet 337(8753):1349
Koenig AS, Abruzzo JL (2002) Leflunomide induced fevers, thrombocytosis, and leukocytosis in a patient with relapsing polychondritis. J Rheumatol 29(1):192–194
Moulis G, Pugnet G, Costedoat-Chalumeau N et al (2018) Efficacy and safety of biologics in relapsing polychondritis: a French National Multicentre Study. Ann Rheum Dis 77(8):1172–1178
Pfister R, Messe M, Niclauss L et al (2019) 18-fluorodeoxyglucose positron emission tomography–computed tomography to guide aortic arch replacement in relapsing polychondritis. Aorta 7(01):018–021
Peng SL, Rodriguez D (2013) Abatacept in relapsing polychondritis. Ann Rheum Dis 72(8):1427–1429
Dion J, Costedoat-Chalumeau N, Sène D et al (2016) Relapsing polychondritis can be characterized by three different clinical phenotypes: analysis of a recent series of 142 patients. Arthritis Rheumatol 68(12):2992–3001
Zheutlin A, Schiopu E (2018) Relapsing polychondritis following treatment with secukinumab for ankylosing spondylitis: case report and review of the literature. Case Rep Rheumatol 2018
Hazra N, Dregan A, Charlton J et al (2015) Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study. Rheumatology 54(12):2181–2187
de la Maza MS, Jabbur NS, Foster CS (1994) Severity of scleritis and episcleritis. Ophthalmology 101(2):389–396
Braithwaite T, Adderley NJ, Subramanian A et al (2021) Epidemiology of scleritis in the United Kingdom from 1997 to 2018: population-based analysis of 11 million patients and association between scleritis and infectious and immune-mediated inflammatory disease. Arthritis Rheumatol 73(7):1267–1276
Kong K, Vasoo S, Tay N et al (2003) Relapsing polychondritis-an oriental case series. Singap Med J 44(4):197–200
Chen N, Zheng Y (2021) Characteristics and clinical outcome of 295 patients with relapsing polychondritis. J Rheumatol (Internet). https://www.jrheum.org/content/early/2021/07/25/jrheum.210062. (Cited 26 Nov 2021
Ferrada M, Rimland CA, Quinn K et al (2020) Defining clinical subgroups in relapsing polychondritis: a prospective observational cohort study. Arthritis Rheumatol 72(8):1396–1402
Shimizu J, Yamano Y, Kawahata K et al (2020) Elucidation of predictors of disease progression in patients with relapsing polychondritis at the onset: potential impact on patient monitoring. BMC Rheumatol 4(1):41
Isaak BL, Liesegang TJ, Michet CJ (1986) Ocular and systemic findings in relapsing polychondritis. Ophthalmology 93(5):681–689
Hoang-Xuan T, Foster CS, Rice BA (1990) Scleritis in relapsing polychondritis: response to therapy. Ophthalmology 97(7):892–898
Paroli M, Priori R, Spinucci G et al (2012) Case report uveitis with retinal occlusive vasculitis and sensorineural hypoacusia as first symptoms of relapsing polychondritis. Clin Exp Rheumatol 30(1 Suppl 70):S101–S103
Van Besien K, Tricot G, Hoffman R (1992) Relapsing polychondritis: a paraneoplastic syndrome associated with myelodysplastic syndromes. Am J Hematol 40(1):47–50
Abrahamsen AM, Bergaust B (1969) Relapsing polychondritis. Acta Med Scand 185(1–6):175–178
Sakuta T, Morita Y, Sakai J et al (2005) A case of Vogt–Koyanagi–Harada disease that developed relapsing polychondritis. Mod Rheumatol 15(3):204–206
Lee SMS, Fan BE, Lim JH-L et al (2021) A case of VEXAS syndrome manifesting as Kikuchi-Fujimoto disease, relapsing polychondritis, venous thromboembolism and macrocytic anaemia. Rheumatology 60(9):e304-6
Ellen NY, Jurkunas U, Rubin PA et al (2006) Obliterative microangiopathy presenting as chronic conjunctivitis in a patient with relapsing polychondritis. Cornea 25(5):621–622
Firestein GS, Gruber HE, Weisman MH et al (1985) Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome. Five patients with features of relapsing polychondritis and Behçet’s disease. Am J Med. 79(1):65–72
Peebo BB, Peebo M, Frennesson C (2004) Relapsing polychondritis: a rare disease with varying symptoms. Acta Ophthalmol Scand 82(4):472–475
Yang P, Yuan W, Du L et al (2019) Clinical features of Chinese patients with relapsing polychondritis. Br J Ophthalmol 103(8):1129–1132
He Y, Liu H, Ji Z, Zhu B (2017) Surgical interventions for late ocular complications of relapsing polychondritis. Am J Ophthalmol Case Rep 5:63–66
Anderson B (1967) Ocular lesions in relapsing polychondritis and other rheumatoid syndromes: the Edward Jackson memorial lecture. Am J Ophthalmol 64(1):35–50
Ridgway HB, Hansotia PL, Schorr WF (1979) Relapsing polychondritis: unusual neurological findings and therapeutic efficacy of dapsone. Arch Dermatol 115(1):43–45
Brink H, Rademakers J, Verbeek A et al (1994) Ocular manifestations of relapsing polychondritis. Doc Ophthalmol 87(2):159–166
Hirunwiwatkul P, Trobe JD (2007) Optic neuropathy associated with periostitis in relapsing polychondritis. J Neuroophthalmol 27(1):16–21
Ikeda T, Yoshida T, Yamamoto H et al (2021) Sequential involvement of oculomotor nerve and optic nerve sheath in relapsing polychondritis. J Neuroophthalmol. https://doi.org/10.1097/WNO.0000000000001321
Ahn S-W, Park M-S, Jeong H-B et al (2017) Relapsing polychondritis presented with encephalitis followed by brain atrophy. Exp Neurobiol 26(1):66
Miura Y, Fukuda K, Taniguchi Y et al (2019) Recurrent optic perineuritis as the first manifestation of relapsing polychondritis. J Neuroophthalmol 39(4):513–514
Wang Z, Pu C, Zhang J et al (2011) Meningoencephalitis or meningitis in relapsing polychondritis: four case reports and a literature review. J Clin Neurosci 18(12):1608–1615
Nara M, Komatsuda A, Togashi M et al (2015) Relapsing polychondritis with encephalitis: a case report and literature review. Intern Med 54(2):231–234
Coha B, Fustar-Preradovic L, Sekelj S et al (2007) Total hearing loss and blindness caused by relapsing polychondritis and myelodysplastic syndrome. Eur Arch Otorhinolaryngol 264(12):1517–1519
Eun YH, Seok H, Shin IS et al (2016) Relapsing polychondritis presenting with inflammatory pseudotumor. Korean J Intern Med 31(5):1003–1005
Wang C-R, Hsu S-M, Chen Y-C et al (2019) Idiopathic sclerosing orbital inflammation in a relapsing polychondritis patient with impaired vision. J Clin Rheumatol 25(6):e82–e83
Crovato F, Nigro A, Marchi RD et al (1980) Exophthalmos in relapsing polychondritis. Arch Dermatol 116(4):383–384
Lichauco JJ, Lauer S, Shigemitsu HH et al (2001) Orbital mucosa-associated lymphoid tissue (MALT)–type lymphoma in a patient with relapsing polychondritis. Arthritis Rheum 44(7):1713–1715
Hosseini SM, Shirzad S, Ghasemi M (2019) Bilateral panuveitis and keratitis as first presentation of relapsing polychondritis. Ocul Immunol Inflamm 27(8):1267–1269
Sundaram M, Rajput A (1983) Nervous system complications of relapsing polychondritis. Neurology 33(4):513–513
Topalkara K, Kaptanoglu E, Akyüz A et al (2003) Relapsing polychondritis with involvement of posterior inferior cerebellar artery causing acute lateral medullary syndrome. JCR J Clin Rheumatol 9(2):92–95
Brod S, Booss J (1988) Idiopathic CSF pleocytosis in relapsing polychondritis. Neurology 38(2):322–322
Neild G, Cameron J, Lessof M et al (1978) Relapsing polychondritis with crescentic glomerulonephritis. Br Med J 1(6115):743–745
Fairweather D, Frisancho-Kiss S, Rose NR (2008) Sex differences in autoimmune disease from a pathological perspective. Am J Pathol 173(3):600–609
Foxman EF, Zhang M, Hurst SD et al (2002) Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation. J Immunol 168(5):2483–2492
Ooi KG-J, Galatowicz G, Calder VL et al (2006) Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype? Clin Med Res 4(4):294–309
Acknowledgements
Thanks go to Anne Williams and Sorrell Williams from the Royal Glamorgan Hospital library for their help in obtaining articles and to Nigel Davies and Claire Gallagher for their proof reading assistance.
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
KG and AA-J contributed to the study conception and design. All authors contributed to data collection and analysis. The first draft of the manuscript was written by KG, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gallagher, K., Al-Janabi, A. & Wang, A. The ocular manifestations of relapsing polychondritis. Int Ophthalmol 43, 2633–2641 (2023). https://doi.org/10.1007/s10792-023-02662-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-023-02662-w